Susceptibility of Patients with Inflammatory Bowel Disease to COVID-19 Compared with Their Households
Anushiravani A, Saberzadeh-Ardestani B, Vahedi H, Fakheri H, Mansour-Ghanaei F, Maleki I, Nasseri-Moghaddam S, Vosoghinia H, Ghadir M, Hormati A, Kasaeian A, Radmard A, Khosravi B, Malekzadeh M, Alatab S, Sadeghi A, Aminisani N, Poustchi H, Sima A, Malekzadeh R. Susceptibility of Patients with Inflammatory Bowel Disease to COVID-19 Compared with Their Households. Middle East Journal Of Digestive Diseases 2022, 14: 182-191. PMID: 36619152, PMCID: PMC9489316, DOI: 10.34172/mejdd.2022.271.Peer-Reviewed Original ResearchInflammatory bowel diseaseAnti-TNF monotherapySevere inflammatory bowel diseasePrevalence of COVID-19Susceptibility of patientsSeverity of inflammatory bowel diseaseTreatment of inflammatory bowel diseaseData of patientsMultivariate logistic regressionFrequency of COVID-19Immunosuppressive agentsRisk of coronavirus disease 2019Associated with COVID-19Multivariate analysisMulti-centerBowel diseasePatientsRisk factorsObservational studyCoronavirus disease 2019Effects of ageMonotherapyLogistic regressionCOVID-19 susceptibilityPrevalence
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply